Advanced Practice Midwife in Conroe, TX Accepting Medicare

3 Advanced Practice Midwife nurses found. Showing 1 - 3

Karen Brock, CNM WHNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 508 Medical Center Blvd Ste 320, Conroe, TX 77304 Phone: 936-523-5790    Fax: 936-760-4612

Ms. Marianne Frances Moore, APRN, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 690 S Loop 336 W Ste 200, Conroe, TX 77304 Phone: 936-525-3600    Fax: 936-525-3624

Sandra D. Martin, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 701 E Davis St, Ste. A., Conroe, TX 77301 Phone: 936-525-2800    Fax: 936-539-4668

News Archive

Phase III results of Lauriad presented at the 49th Annual ICAAC

BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.

Merz Pharma Group granted early termination in connection with BioForm Medical share tender offer

Merz Pharma Group today announced that it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by Merz GmbH & Co. KGaA ("Merz") and its acquisition subsidiary to purchase all outstanding shares of common stock of BioForm Medical, Inc..

PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA

The President's Emergency Plan for AIDS Relief program has suspended funding for three antiretroviral drugs manufactured by Indian generic drugmaker Ranbaxy that were included in an importation ban imposed by FDA on Sept. 16, Bloomberg reports.

Coridon demonstrates 100% protection using DNA HSV-2 vaccine

DNA vaccine development company Coridon Pty Ltd. today announced that it had successfully completed pre-clinical efficacy testing of its prototype Herpes Simplex Virus 2 (HSV-2) vaccine, with outstanding results. The company will now look to progress the program into clinical studies.

Read more Medical News

› Verified 6 days ago